<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365332">
  <stage>Registered</stage>
  <submitdate>23/04/2014</submitdate>
  <approvaldate>9/05/2014</approvaldate>
  <actrnumber>ACTRN12614000487617</actrnumber>
  <trial_identification>
    <studytitle>Is bispectral index monitoring  useful to assess the quality of analgesia in patients under general anesthesia?</studytitle>
    <scientifictitle>Induction of general anesthesia and laryngoscopy with and without remifentanil: can bispectral index predict and/or detect the lack of analgesia?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>General anesthesia</healthcondition>
    <healthcondition>Analgesia</healthcondition>
    <healthcondition>measuring depth of anesthesia</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>- Patients were randomized in 2 groups.
- Group P: induction of anesthesia performed by propofol alone.
- Group PR: induction of anesthesia performed by propofol and remifentanil.
- Propofol administration was performed in the 2 groups by target-controlled infusion (TCI) using Schnider model. We targeted a plasmatic concentration of 6ug/ml obtained over 2 minutes. 
- Remifentanil administration was performed in the PR group by TCI using Minto model. We targeted a cerebral concentration of 4ng/ml.
- We noted the arterial pressure, heart rate and bispectral index (BIS) each minute. 
- As BIS reached 60, consumption and cerebral concentration of propofol and time elapsed since the initiation of the induction were noted. Then, we fixed the plasmatic concentration of propofol to the cerebral concentration noted.
- A muscle relaxing agent was administered and a laryngoscopy with endotracheal intubation was performed.
- BIS, heart rate and arterial pressure were noted before and in the 2 minutes following laryngoscopy.</interventions>
    <comparator>Group P, where induction of anesthesia is performed by propofol alone.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Difference in DeltaBIS (maximum of BIS after laryngoscopy - BIS before laryngoscopy) between the P and the PR group.</outcome>
      <timepoint>2 minutes after laryngoscopy</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Correlation between DeltaBIS and DeltaHeartRate. Heart rate is assessed by continuous electrocardiogram.</outcome>
      <timepoint>2 minutes after laryngoscopy</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Correlation between DeltaBIS and DeltaArterialPressure. Arterial pressure is assessed by automated pneumatic cuff.</outcome>
      <timepoint>2 minutes after laryngoscopy</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- ASA class 1 or 2.
- Proposed for elective surgery.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- Predicted difficult intubation.
- Hard-to-control hypertension.
- Coronaropathy.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence>Simple randomisation by coin-tossing patient by patient</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>DeltaBIS, DeltaHeartRate and DeltaArterialPressure compared using t-student test.
Correlation measured by Pearson correlation coefficient.
The needed number of participants was calculated using the results of a previous study (Anesth Analg 1998;87:949-55). It was calculated on the basis of the primary outcome, with a power of 0,8 and an error risk of 0,05. We found a needed number of 28 in each group.
</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>12/05/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Tunisia</country>
      <state>Tunis</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Hopital Militaire Principal d'Instruction de Tunis</primarysponsorname>
    <primarysponsoraddress>Montfleury  1008 Tunis</primarysponsoraddress>
    <primarysponsorcountry>Tunisia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Hopital Militaire Principal d'Instruction de Tunis</fundingname>
      <fundingaddress>Montfleury  1008 Tunis </fundingaddress>
      <fundingcountry>Tunisia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Bispectral index is a device used to monitor depth of anesthesia. Studies showed that it was well correlated with hypnotics, especially when used alone. Some data suggest that it can detect lack of analgesia. Our primary purpose was to test the ability of bispectral index to detect and/or predict the quality of analgesia.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comit√© d'ethique local de l'Hopital Militaire de Tunis</ethicname>
      <ethicaddress>Montfleury - 1008 Tunis</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>25/04/2014</ethicsubmitdate>
      <ethiccountry>Tunisia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Abderrahmen Bargaoui</name>
      <address>Hopital Militaire de Tunis. Montfleury 1008 Tunis</address>
      <phone>+21622849078</phone>
      <fax />
      <email>bargaoui.abd@gmail.com</email>
      <country>Tunisia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Abderrahmen Bargaoui</name>
      <address>Hopital Militaire de Tunis. Montfleury 1008 Tunis</address>
      <phone>+21622849078</phone>
      <fax />
      <email>bargaoui.abd@gmail.com</email>
      <country>Tunisia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Abderrahmen Bargaoui</name>
      <address>Hopital Militaire de Tunis. Montfleury 1008 Tunis</address>
      <phone>+21622849078</phone>
      <fax />
      <email>bargaoui.abd@gmail.com</email>
      <country>Tunisia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>